For semaglutide, Beggs test showed no evidence of bias (Kendalls tau b = 0.03571, p = 0.90154), and Eggers test also indicated no small-study effects (intercept = -0.18380, p = 0.58764)
For people with obesity-related conditions like type 2 diabetes, cardiovascular disease, or sleep apnea, that delay carries medical risk
Hair loss occurs in a subset of patients, typically related to rapid weight loss rather than the medication directly
Countries with significant sales include the United States, Canada, Mexico, the United Kingdom, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, South Africa, the United Arab Emirates, Kuwait, and Saudi Arabia [66]